Which hedge funds own EMR? EMERSON ELEC CO, Q2 2026 13F holders
Industrials · Open on the interactive board
14 of the hedge funds tracked by WhaleCreep disclosed a position in EMR (EMERSON ELEC CO) in their Q2 2026 13F filings, worth $324.7m in total. The largest holder by portfolio weight is Hite Hedge Asset Management at 0.3% of its book. 3 managers opened a new position this quarter: Hite Hedge Asset Management, Point72 Asset Management LP, Brevan Howard Capital Management.
14tracked managers holding
3opened this quarter
0exited this quarter
Which hedge funds hold EMR? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Hite Hedge Asset Management | Q2 2026 | 0.3% | $4.7m | 32,855 | – | new |
| Point72 Asset Management LP | Q2 2026 | 0.1% | $79.8m | 557,706 | – | new |
| Tweedy Browne | Q2 2026 | 0.1% | $1.3m | 8,743 | -2% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.1% | $104.2m | 728,223 | 4% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $64.9m | 453,070 | -49% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $40.0m | 279,107 | -20% | reduced |
| Horizon Kinetics | Q2 2026 | 0.0% | $2.4m | 16,592 | 0% | held |
| Woodline Partners | Q2 2026 | 0.0% | $8.1m | 56,914 | -34% | reduced |
| Bridgewater Associates | Q2 2026 | 0.0% | $5.2m | 36,541 | -73% | reduced |
| First Manhattan | Q2 2026 | 0.0% | $8.4m | 58,352 | -3% | reduced |
| Ancora Advisors | Q2 2026 | 0.0% | $745.7k | 5,209 | -4% | reduced |
| Tudor Investment | Q2 2026 | 0.0% | $3.3m | 23,208 | -88% | reduced |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $697.4k | 4,872 | – | new |
| Millennium Management | Q2 2026 | 0.0% | $953.0k | 6,657 | -69% | reduced |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| Boston Omaha | Q4 2024 | 0.1% |
How has hedge fund ownership of EMR changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 14 | $324.7m |
| Q1 2026 | 11 | $323.7m |
| Q4 2025 | 6 | $26.9m |
| Q3 2025 | 6 | $24.7m |
| Q2 2025 | 6 | $17.2m |
| Q1 2025 | 6 | $16.8m |
| Q4 2024 | 8 | $65.2m |
| Q3 2024 | 9 | $169.7m |
| Q2 2024 | 13 | $229.5m |
| Q1 2024 | 11 | $261.4m |
| Q4 2023 | 9 | $201.3m |
| Q3 2023 | 10 | $137.9m |
| Q2 2023 | 11 | $325.8m |
| Q1 2023 | 13 | $459.5m |
| Q4 2022 | 9 | $91.7m |
| Q3 2022 | 13 | $154.0m |
Counts every tracked manager that disclosed EMR in that quarter's filing, including managers that have since stopped filing.